Viveve Medical, Inc. (VIVE)
OTCMKTS: VIVE · Delayed Price · USD
0.0003
+0.0001 (50.00%)
Apr 19, 2024, 11:51 AM EDT - Market closed
Viveve Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.43 | 5.48 | 6.57 | 18.52 | 15.29 | 7.14 | 1.45 | 0.09 | 1.27 | 1.08 | Upgrade
|
Revenue Growth (YoY) | 17.28% | -16.57% | -64.54% | 21.12% | 114.09% | 393.50% | 1507.78% | -92.94% | 17.96% | 60.95% | Upgrade
|
Cost of Revenue | 5.81 | 5.18 | 5.55 | 11.2 | 7.84 | 4.61 | 0.99 | 0.05 | 0.53 | 0.54 | Upgrade
|
Gross Profit | 0.62 | 0.3 | 1.02 | 7.32 | 7.44 | 2.53 | 0.46 | 0.04 | 0.74 | 0.54 | Upgrade
|
Selling, General & Admin | 12.51 | 13.67 | 22.36 | 38.57 | 28.83 | 12.87 | 7.46 | 4.28 | 3.33 | 2.63 | Upgrade
|
Research & Development | 9.67 | 5.13 | 8.59 | 13.72 | 12.34 | 8.37 | 4.99 | 1.43 | 2.12 | 2.03 | Upgrade
|
Other Operating Expenses | -0.2 | -0.29 | -0.16 | 0.01 | 0 | 0 | 0 | 0.05 | 0 | 0 | Upgrade
|
Operating Expenses | 22.17 | 18.79 | 30.95 | 52.29 | 41.17 | 21.23 | 12.45 | 5.7 | 5.45 | 4.66 | Upgrade
|
Operating Income | -21.55 | -18.5 | -29.94 | -44.97 | -33.73 | -18.7 | -11.99 | -5.66 | -4.7 | -4.13 | Upgrade
|
Interest Expense | 1 | 0.91 | 4.35 | 4.37 | 3.17 | 1.37 | 0.42 | 0.57 | 0.34 | 0.56 | Upgrade
|
Other Expense / Income | -0.78 | 2.13 | 7.61 | -0.01 | 0.06 | -1.22 | -0.32 | -0.67 | -8.88 | 3.15 | Upgrade
|
Pretax Income | -21.77 | -21.53 | -41.9 | -49.32 | -36.96 | -20.11 | -12.43 | -6.18 | 3.5 | -8.39 | Upgrade
|
Income Tax | 1.05 | -0.29 | 4.82 | -0.14 | -0.33 | 1.26 | 0.34 | 0.62 | 0.34 | 0.56 | Upgrade
|
Net Income | -22.82 | -21.24 | -46.72 | -49.18 | -36.63 | -20.11 | -12.43 | -6.18 | 3.5 | -8.39 | Upgrade
|
Shares Outstanding (Basic) | 10 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 10 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change | 541.22% | 1161.00% | 301.76% | 77.52% | 89.72% | 83.63% | 123.00% | 1343.59% | 290.00% | 8.11% | Upgrade
|
EPS (Basic) | -2.26 | -13.50 | -374.40 | -1583.50 | -2093.62 | -2180.76 | -2474.31 | -2744.23 | 22429.49 | -209675.00 | Upgrade
|
EPS (Diluted) | -2.26 | -13.50 | -374.40 | -1583.50 | -2093.62 | -2180.76 | -2474.31 | -2744.23 | 22429.49 | -209675.00 | Upgrade
|
Free Cash Flow | -13.33 | -16.02 | -32.32 | -45.23 | -35.76 | -18.34 | -12.3 | -6.11 | -4.8 | -3.24 | Upgrade
|
Free Cash Flow Per Share | -1.32 | -10.18 | -259.03 | -1456.33 | -2043.78 | -1989.05 | -2450.02 | -2712.26 | -30794.87 | -80975.00 | Upgrade
|
Gross Margin | 9.65% | 5.40% | 15.47% | 39.53% | 48.69% | 35.42% | 31.93% | 44.44% | 58.32% | 49.91% | Upgrade
|
Operating Margin | -335.40% | -337.56% | -455.87% | -242.83% | -220.63% | -261.92% | -828.61% | -6291.11% | -369.23% | -381.94% | Upgrade
|
Profit Margin | -355.18% | -387.64% | -711.42% | -265.60% | -239.60% | -281.63% | -858.74% | -6866.67% | 274.65% | -776.57% | Upgrade
|
Free Cash Flow Margin | -207.50% | -292.30% | -492.20% | -244.27% | -233.90% | -256.87% | -850.31% | -6786.67% | -377.08% | -299.91% | Upgrade
|
Effective Tax Rate | - | - | - | - | - | - | - | - | 9.63% | - | Upgrade
|
EBITDA | -20.62 | -18.78 | -28.92 | -44.97 | -33.67 | -18.7 | -11.99 | -5.56 | -4.65 | -4.08 | Upgrade
|
EBITDA Margin | -320.84% | -342.84% | -440.32% | -242.83% | -220.24% | -261.92% | -828.61% | -6174.44% | -365.07% | -377.96% | Upgrade
|
Depreciation & Amortization | 1.14 | 1.3 | 1.18 | 0.79 | 0.45 | 0.11 | 0.08 | 0.06 | 0.05 | 0.04 | Upgrade
|
EBIT | -21.76 | -20.08 | -30.1 | -45.75 | -34.12 | -18.82 | -12.07 | -5.61 | -4.7 | -4.13 | Upgrade
|
EBIT Margin | -338.56% | -366.51% | -458.32% | -247.08% | -223.18% | -263.48% | -833.93% | -6236.67% | -369.23% | -381.94% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.